What makes an autoantigen an autoantigen?

Annals of the New York Academy of Sciences

Volumn 1050, Issue , 2005, Pages 134-145

  Wu, Chih Te ^a   Gershwin, M Eric ^a   Davis, Paul A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigens; Autoimmunity; Immune system; Posttranslational modification; Primary biliary cirrhosis; Protein function

Indexed keywords

AUTOANTIGEN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING;

EID: 23744451238     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1313.015     Document Type: Conference Paper

References (45)

1. BARRA, H.S., C.A. ARCE & C.E. ARGARANA. 1988. Posttranslational tyrosination/detyrosination of tubulin. Mol. Neurobiol. 2: 133-153.
2. WESTERMANN, S. & K. WEBER. 2003. Post-translational modifications regulate microtubule function. Nat. Rev. Mol. Cell Biol. 4: 938-947.
3. KATO, C., K. MIYAZAKI, A. NAKAGAWA, et al. 2004. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis. Int. J. Cancer 112: 365-375.
4. RAM, T.G., R. REEVES & H.L. HOSICK. 1993. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 53: 2655-2660.
5. EDBERG, D.D., J.E. BRUCE, W.F. SIEMS & R. REEVES. 2004. In vivo posttranslational modifications of the high mobility group Ala proteins in breast cancer cells of differing metastatic potential. Biochemistry 43: 11500-11515.
6. WEISER, J.N., J.B. GOLDBERG, N. PAN, et al. 1998. The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae. Infect. Immunol. 66: 4263-4267.
7. HEGGE, F.T., P.G. HITCHEN, F.E. AAS, et al. 2004. Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili. Proc. Natl. Acad. Sci. USA 101: 10798-10803.
8. RESSING, M.E., D. VAN LEEUWEN, P.A. VERRECK, et al. 2005. Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J. Virol. 79: 841-852.
9. GOEDERT, M. 2001. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. Curr. Opin. Genet. Dev. 11: 343-351.
10. LEE, V.M., M. GOEDERT & J.Q. ROJANOWSKI. 2001. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24: 1121-1159.
11. CUNNINGHAM, B.A., S. HOFFMAN, U. RUTISHAUSER, et al. 1983. Molecular topography of the neural cell adhesion molecule N-CAM: surface orientation and location of sialic acid-rich and binding regions. Proc. Natl. Acad. Sci. USA 80: 3116-3120.
12. RUTISHAUSER, U., M. WATANABE, J. SILVER, et al. 1985. Specific alteration of NCAM-mediated cell adhesion by an endoneuraminidase. J. Cell Biol. 101: 1842-1849.
13. CONE, R.D. 1999 The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 10: 211-216.
14. GUO, L., H. MUNZBERG, R.C. STUART, et al. 2004. N-Acetylation of hypothalamic alpha-melanocyte-stimulating hormone and regulation by leptin. Proc. Natl. Acad. Sci. USA 101: 11797-11802.
15. DREYER, W.J. & H. NEURATH. 1955. The activation of chymotrypsinogen; isolation and identification of a peptide liberated during activation. J. Biol. Chem. 217: 527-539.
16. WU, Y.I., H.G. MUNSHI, R. SEN, et al. 2004. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J. Biol. Chem. 279: 8278-8289.
17. WONG, P.S., J.P. EISERICH, S. REDDY, et al. 2001. Inactivation of glutathione S-transferases by nitric oxide-derived oxidants: exploring a role for tyrosine nitration. Arch. Biochem. Biophys. 394: 216-228.
18. GIULIVI, C. 1998. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem. J. 332: 673-679.
19. GERDES, J., H. LEMKE, H. BAISCH, et al. 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133: 1710-1715.
20. ENDL, E. & J. GERDES. 2000. Posttranslational modifications of the KI-67 protein coincide with two major checkpoints during mitosis. J. Cell. Physiol. 182: 371-380.
21. SMOTRYS, J.E. & M.E. LINDER. 2004. Palmitoylation of intracellular signaling proteins: regulation and function. Annu. Rev. Biochem. 73: 559-587.
22. BROWN, D.A. & E. LONDON. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14: 111-136.
23. KABOURIDIS, P.S., A.I. MAGEE & S.C. LEY. 1997. 5-Acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes. EMBO J. 16: 4983-4998.
24. SEABRA, M.C. 1998. Membrane association and targeting of prenylated Ras-like GTPases. Cell. Signal. 10: 167-172.
25. CALERO, M., C.Z. CHEN, W. ZHU, et al. 2003. Dual prenylation is required for Rab protein localization and function. Mol. Biol. Cell 14: 1852-1867.
26. RADEMACHER, T.W., S.W. HOMANS, R.B. PAREKH & R.A. DWEK. 1986. Immunoglobulin G as a glycoprotein. Biochem. Soc. Symp. 51: 131-148.
27. COLOMA, M.J., A. CLIFT, L. WIMS & S.L. MORRISON. 2000. The role of carbohydrate in the assembly and function of polymeric IgG. Mol. Immunol. 37: 1081-1090.
28. BRANDTZAEG, P. & H. PRYDZ. 1984. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 311: 71-73.
29. REISNER, Y., M. LINKER-ISRAELI & N. SHARON. 1976. Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin. Cell. Immunol. 25: 129-134.
30. ROBB, R.J., R.M. KUTNY, M. PANICO, et al. 1984. Amino acid sequence and post-translational modification of human interleukin 2. Proc. Natl. Acad. Sci. USA 81: 6486-6490.
31. SANTHANAM, U., J. GHRAYEB, PB. SEHGAL & L.T. MAY. 1989. Post-translational modifications of human interleukin-6. Arch. Biochem. Biophys. 274: 161-170.
32. VIGNERON, N., V. STROOBANT, J. CHAPIRO, et al. 2004. An antigenic peptide produced by peptide splicing in the proteasome. Science 304: 587-590.
33. HANADA, K., J.W. YEWDELL & J.C. YANG. 2004. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427: 252-256.
34. MOWEN, K.A., B.T. SCHURTER, J.W. FATHMAN, et al. 2004. Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes. Mol. Cell 15: 559-571.
35. SEBBAG, M., M. SIMON, C. VINCENT, et al. 1995. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 95: 2672-2679.
36. GAN, S.Q., O.W. MCBRIDE, W.W. IDLER, et al. 1990. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry 29: 9432-9440.
37. GIRBAL-NEUHAUSER, E., J.J. DURIEUX, M. ARNAUD, et al. 1999. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J. Immunol. 162: 585-594.
38. MYERS, L.K., J. MYLLYHARJU, M. NOKELAINEN, et al. 2004. Relevance of posttranslational modifications for the arthritogenicity of type II collagen. J. Immunol. 172: 2970-2975.
39. YAMADA, H., B. DZHAMBAZOV, R. BOCKERMANN, et al. 2004. A transient post-translationally modified form of cartilage type II collagen is ignored by self-reactive T cells. J. Immunol. 173: 4729-4735.
40. MAMULA, M.J., R.J. GEE, J.I. ELLIOTT, et al. 1999. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J. Biol. Chem. 274: 22321-22327.
41. DE HAAN, E.C., J.P. WAGENAAR-HILBERS, R.M. LISKAMP, et al. 2005. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides. Mol. Immunol. 42: 355-364.
42. SURH, C.D., R. COPPEL & M.E. GERSHWIN. 1990. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis: implication for a conformational autoepitope. J. Immunol. 144: 3367-3374.
43. QUINN, J., A.G. DIAMOND, J.M. PALMER, et al. 1993. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 18: 1384-1391.
44. LONG, S.A., C. QUAN, J. VAN DE WATER, et al. 2001. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J. Immunol. 167: 2956-2963.
45. LEUNG, P.S., C. QUAN, O. PARK, et al. 2003. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J. Immunol. 170: 5326-5332.